Psychiatric comorbidity among adults with schizophrenia: A latent class analysis

Psychiatry Research

Volumn 210, Issue 1, 2013, Pages 16-20

  Tsai, Jack ^a,b   Rosenheck, Robert A ^c  

^a VA New England Mental Illness Research   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Anxiety; Classification; Depression; Diagnosis; Methods; Substance related disorders

Indexed keywords

ADDICTION; ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; ATTITUDE TO HEALTH; COMORBIDITY; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; INTROSPECTION; LATENT CLASS ANALYSIS; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL HEALTH; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROGNOSIS; SCHIZOPHRENIA; STATISTICAL ANALYSIS; UNITED STATES;

ANXIETY; CLASSIFICATION; DEPRESSION; DIAGNOSIS; METHODS; SUBSTANCE-RELATED DISORDERS;

ADULT; ALCOHOLISM; ANXIETY; COMORBIDITY; FEMALE; HUMANS; MALE; MENTAL DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84885858398     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.05.013     Document Type: Article

References (46)

1. Achim A.M., Maziade M., Raymond E., Olivier D., Merette C., Roy M.A. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophrenia Bulletin 2011, 37(4):811-821.
2. Addington D., Addington J., Maticka-Tyndale E., Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research 1992, 6:201-208.
3. Akaike H. Factor analysis and AIC. Psychometrika 1987, 52(3):317-332.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, Author, Washington, DC. 4th ed., text revision.
5. Andreasen N.C., Flaum M., Swayze V.W., Tyrrell G., Arndt S. Positive and negative symptoms in schizophrenia: a critical reappraisal. Journal of the American Medical Association 1990, 47(7):615-621.
6. Bottas A., Cooke R.G., Richter M.A. Comorbidity and pathophysiology of obsessive-compuslive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia?. Journal of Psychiatry and Neuroscience 2005, 30(3):187-193.
7. Buckley P.F., Miller B.J., Lehrer D.S., Castle D.J. Psychiatric comorbidities and schizophrenia. Schizophrenia Bulletin 2009, 35(2):383-402.
8. Drake R.E., Mueser K.T., Brunette M.F. Management of persons with co-occurring severe mental illness and substance use disorder: program implications. World Psychiatry 2007, 6(3):131-136.
9. Emsley R.A., Oosthuizen P.P., Joubert A.F., Roberts M.C., Stein D.J. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. Journal of Clinical Psychiatry 1999, 60(11):747-750.
10. Fazel S., Langstrom N., Hjern A., Grann M., Lichtensein P. Schizophrenia, substance abuse, and violent crime. Journal of the American Medical Association 2009, 301(19):2016-2023.
11. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorder-Patient Edition 1997, New York State Psychiatric Institute, New York.
12. Garvey M., Noyes R., Anderson D., Cook B. Examination of comorbid anxiety in psychiatric inpatients. Comprehensive Psychiatry 1991, 32(4):277-282.
13. Ginzburg K., Ein-Dor T., Solomon Z. Comorbidity of posttraumatic stress disorder, anxiety and depression: a 20-year longitudinal study of war veterans. Journal of Affective Disorders 2010, 123(1-3):249-257.
14. Hofer A., Kemmler G., Eder U., Edlinger M., Hummer M., Fleischhacker W.W. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects. Journal of Clinical Psychiatry 2004, 65(7):932-939.
15. Jung T., Wickrama K.A.S. An introduction to latent class growth analysis and growth mixture modeling. Social and Personality Psychology Compass 2008, 2(1):302-317.
16. Kay S.R., Fiszbein A., Opfer L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:261-276.
17. Kessler R.C., Crum R.M., Warner L.A., Nelson C.B., Schulenberg J., Anthony J.C. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry 1997, 54(4):313-321.
18. Kessler R.C., McGonagle K.A., Zhao S., Nelson C., Hughes M., Eschleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the US: results from the National Comorbidity Survey. Archives of General Psychiatry 1994, 51(1):8-19.
19. Khantzian E.J. The self-medication hypothesis of addictive disorder: focus on heroin and cocaine dependence. American Journal of Psychiatry 1985, 142(11):1259-1264.
20. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry 1997, 4(5):231-244.
21. Lehman A. A quality of life interview for the chronically mentally ill. Evaluation and Program Planning 1988, 11:51-62.
22. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S.E., Davis S.M., Davis C.E., Lebowitz B.D., Severe J., Hsiao J.K., CATIE Investigators Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 2005, 353(12):1209-1223.
23. Lincoln T.M., Lullmann E., Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia: a systematic review. Schizophrenia Bulletin 2007, 33(6):1324-1342.
24. Lo Y., Mendell N.R., Rubin D.B. Testing the number of components in a normal mixture. Biometrika 2001, 88(3):767-778.
25. Markou A., Kosten T.R., Koob G.F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998, 18(3):135-174.
26. McEvoy J.P., Apperson J., Appelbaum P.S., Ortlip P., Brecosky J., Hammill K., Geller J.L., Roth L. Insight in schizophrenia: its relationship to acute psychopathology. Journal of Nervous and Mental Disease 1989, 177:43-47.
27. McLachlan G.J. On bootstrapping the likelihood ratio test statistic for the number of components in a normal mixture. Applied Statistics 1987, 36(3):318-324.
28. Mueser K.T., Bellack A.S., Blanchard J.J. Comorbidity of schizophrenia and substance abuse: implications for treatment. Journal of Consulting and Clinical Psychology 1992, 60(5):845-856.
29. Muthen B. Latent variable analysis: growth mixture modeling and related techniques for longitudinal data. Handbook of Quantitative Methodology for the Social Sciences 2004, Sage Publications, Thousand Oaks, CA, pp. 345-368. D. Kaplan (Ed.).
30. Nylund K.L., Asparouhov T., Muthen B.O. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Structural Equation Modeling 2007, 14(4):535-569.
31. O'Daly O.G., Guillin O., Tsapakis E.M., Martinez D., Shergill S.S., Murray R.M. Schizophrenia and substance abuse comorbidity: a role for dopamine sensitization?. Journal of Dual Diagnosis 2005, 1(2):11-40.
32. Pijnenborg G.H., van Donkersgoed R.J., David A.S., Aleman A. Changes in insight during treatment for psychotic disorders: a meta-analysis. Schizophrenia Research 2013, 144(1-3):109-117.
33. Pini S., Cassano G.B., Dell'Osso L., Amador X.F. Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features. American Journal of Psychiatry 2001, 158(1):122-125.
34. Poyurovsky M., Kriss V., Weisman G., Faragian S., Kurs R., Schneidman M., Fuchs C., Weizman A., Weizman R. Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia. Journal of Clinical Psychiatry 2003, 64(11):1300-1307.
35. RachBeisel J., Scott J., Dixon L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatric Services 1999, 50(11):1427-1434.
36. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Journal of American Medical Association 1990, 264:2511-2518.
37. Schwarz G. Estimating the dimension of a model. Annals of Statistics 1978, 6(2):461-464.
38. Sim K., Mahendran R., Siris S.G., Heckers S., Chong S.A. Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Research 2004, 129(2):141-147.
39. Stroup T.S., McEvoy J.P., Swartz M.S., Byerly M.J., Glick R.D., Canive J.M., McGee M.F., Simpson G.M., Stevens M.C., Lieberman J.A. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizoprhenia trial design and protocol development. Schizophrenia Bulletin 2003, 29:15-31.
40. Swendsen J.D., Tennen H., Carney M.A., Affleck G., Willard A., Hromi B. Mood and alcohol consumption: an experience sampling test of the self-medication hypothesis. Journal of Abnormal Psychology 2000, 109(2):198-204.
41. Tibbo P., Swainson J., Chue P., LeMelledo J.M. Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia. Depression and Anxiety 2003, 17(2):65-72.
42. Volkow N.D. Substance use disorders in schizophrenia-clinical implications of comorbidity. Schizophrenia Bulletin 2009, 35(3):469-472.
43. Ware J.E., Kosinski M., Keller S.D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Medical Care 1996, 34(3):220-233.
44. Watson D. Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V. Journal of Abnormal Psychology 2005, 114(4):522-536.
45. Weich S., McGride O., Hussey D., Exeter D., Brugha T., McManus S. Latent class analysis of co-morbidity in the Adult Psychiatric Morbidity Survey in England 2007: implications for DSM-5 and ICD-11. Psychological Medicine 2011, 41(10):2201-2212.
46. Wolf E.J., Miller M.W., Reardon A.F., Ryabchenko K.A., Castillo D., Freund R. A latent class analysis of dissociation and posttraumatic stress disorder. Archives of General Psychiatry 2012, 69(7):698-705.